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ABSTRACT 
 
MED12 is a member of the large Mediator complex that controls cell growth, development, 
and differentiation. Mutations in MED12 disrupt neuronal gene expression and lead to at least 
three distinct X-linked intellectual disability (XLID) syndromes (FG, Lujan-Fryns, and 
Ohdo). Here we describe six families with missense variants in MED12 (p.(Arg815Gln), 
p.(Val954Gly), p.(Glu1091Lys), p.(Arg1295Cys), p.(Pro1371Ser) and p.(Arg1148His), the 
latter being  firstly reported in affected females) associated with a continuum of symptoms 
rather than distinct syndromes. The variants expanded the genetic architecture and phenotypic 
spectrum of MED12-related disorders. New clinical symptoms included brachycephaly, 
anteverted nares, bulbous nasal tip, prognathism, deep set eyes, and single palmar crease. We 
showed that MED12 variants, initially implicated in X-linked recessive disorders in males, 
may predict a potential risk for phenotypic expression in females, with no correlation of the X 
chromosome inactivation pattern in blood cells. Molecular modeling (Yasara Structure) 
performed to model the functional effects of the variants strongly supported the pathogenic 
character of the variants examined. We demonstrated that molecular modeling is a useful 
method for in silico testing of potential functional effects of MED12 variants and thus can be 
a valuable addition to the interpretation of the clinical and genetic findings.  
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MED12, X-linked intellectual disability, FG syndrome, Lujan-Fryns syndrome, Ohdo 
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INTRODUCTION 
 The Mediator is a large multiprotein complex that regulates gene expression in all 
eukaryotes and interacts with RNA polymerase II. The role of the complex involves 
transcriptional elongation and termination, mRNA processing, noncoding RNA activation, 
super enhancer formation, and epigenetic regulation. Thus, the Mediator was called an 
‘‘integrative hub’’ for transcriptional processes and emerged as a master coordinator of cell 
growth and homeostasis, development, and differentiation
1
. The Mediator complex (MED) 
consists of 31 subunits (MED1-MED31) and can be divided into four distinct modules termed 
as the head, middle, tail, and CDK8 kinase module. The latter module contains CDK8, cyclin 
C, MED12 and MED13. MED12 is a critical transducer of regulatory information essential 
for organogenesis. At least three different intellectual disability (ID) conditions that are 
associated with MED12 mutations have been described. These conditions include Opitz-
Kaveggia syndrome (FG syndrome type 1, FGS1), Lujan-Fryns syndrome (LFS), and X-
linked Ohdo syndrome (XLOS, OHDOX)
2
. These syndromes are allelic disorders that share 
clinical findings including ID, hypotonia and some physical features, such as tall prominent 
forehead, open mouth or high narrow palate. Probands with non-syndromic X-linked ID 
(XLID), including females with variable cognitive impairment, have also been described as 
harboring MED12 mutations. Here, we present clinical and genetic details on six families 
with missense variants in the MED12 gene, as well as molecular modeling results for four 
variants, and expand the phenotypic spectrum of MED12-related disorders. 
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MATERIALS AND METHODS 
Six ID families with MED12 variants (NM_005120) were included in the study (Fig.1). 
Patients’ phenotypes are described in Supplementary material 1 and summarized in 
Supplementary material 2. Families 1 to 4 were collected as part of the X-exome 
resequencing project of unresolved families with assumed XLID, while Families 5 and 6 were 
sequenced in routine diagnostics. For none of the families a clinical suggestion had been 
made prior to next generation sequencing (NGS). The procedures employed were reviewed 
and approved by the appropriate institutional review committees. DNAs were isolated from 
peripheral blood according to standard procedures. Written informed consent was obtained for 
all individuals participating in this study. For the index probands NGS was performed in three 
laboratories (Berlin, Tübingen, and Warsaw) as described in Supplementary material 3. 
Segregation analysis was performed by Sanger sequencing for the other available family 
members. The pathogenicity of variants obtained from NGS was assessed by molecular 
modeling (Yasara Structure) as described in Supplementary material 3.  
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RESULTS 
We report on 13 affected males and 2 affected females from 6 families with variants in the 
MED12 gene (Fig. 1). Clinical symptoms of the affected males and females along with a 
comparison with symptoms described in published MED12-related syndromes are presented 
in Table 1. All probands had ID and developmental delay, most of them had macrocephaly, 
long narrow face, prominent forehead, small ears, dental abnormalities, prognathism and 
hypertelorism. The remaining clinical features were variable. The new clinical findings 
associated with MED12 variants (present in at least 2 families) were as follows: 
brachycephaly, anteverted nares, bulbous nasal tip, prognathism, deep set eyes, and single 
palmar crease. In the families we identified 3 novel missense variants in MED12 
(p.(Val954Gly), p.(Glu1091Lys), p.(Pro1371Ser)), 1 known variant but firstly reported in 
affected females (p.(Arg1148His)), as well as 2 variants (p.(Arg815Gln) and p.(Arg1295Cys)) 
which have already been described as a cohort data by the authors of the current paper, but 
without clinical details of the presented families
3,4
. 
 All MED12 variants identified in the families perfectly co-segregated with the 
phenotype, except for Family 5 in whom the MED12 variant present in the affected daughters 
was inherited from the healthy mother. Most of the variants were absent in the gnomAD 
database (except for c.2444G>A present in 1 heterozygous female with a minor allele 
frequency (MAF) of 5.599e-6 and c.4111C>T present in 6 hemizygous individuals with a 
MAF of 0.00012).  All the variants were predicted as damaging by Polyphen2, 
MutationTaster, as well as SIFT,  except for c.4111C>T identified in patient III:1 from 
Family 6 which had conflicting interpretations of pathogenicity (Polyphen2 – benign, 
Mutation Taster – disease causing, SIFT – tolerated). Additionally, this variant had been 
reported  to ClinVar as likely benign. NGS performed subsequently in the patient revealed 
additionally a de novo heterozygous missense variant c.367C>T in the PUF60 gene 
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(NM_078480.2) resulting in the p.(Arg123Trp) substitution. The variant was predicted as 
damaging (Polyphen2, MutationTaster, SIFT) and it was absent in gnomAD database. 
Molecular modeling was applied to assess the functional effects of the MED12 (four 
of the six identified MED12 substitutions are located within the protein regions, the structure 
of which may be reasonably modeled by homology) and PUF60 variants identified by NGS. 
All the variants are expected to have substantial structural effects on proteins (Fig. 2).  
X chromosome inactivation (XCI) analysis performed in Family 4 revealed that the 
mother (II:1) of the index patient (III:2) who also carried the mutation had mildly skewed 
XCI (83:17) in her blood cells. In Family 5 XCI analysis revealed a mildly skewed pattern in 
the mother (82:18) and a skewed pattern in her two affected daughters (100:0 and 85:15). In 
the three females, the same allele of the AR locus was inactive.  
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DISCUSSION 
The phenotypic spectrum of MED12-related disorders is still being expanded as new 
families with MED12 variants are being identified due to the improvement of new sequencing 
technologies. Moreover, it was postulated that succeeding syndromes should be defined to 
extend the list of the three allelic syndromes associated with MED12 mutations. However, as 
shown by the clinical data of our probands (Table 1) it seems that they do not manifest strict 
syndromes (FGS1, Lujan-Fryns or Ohdo), but they rather present, similar to recently 
published data
5
, a continuum of symptoms. Thus, it is more appropriate to indicate only a 
‘MED12-related disorder’ than to attribute a definite syndrome for a majority of the subjects. 
To date, over 20 MED12 genetic variants have been reported which are evenly 
distributed with no apparent hot spots in specific exons (Fig. 1). All but one were missense 
variants causing FGS1, Lujan-Fryns, Ohdo syndrome or non-syndromic ID with different 
degrees of cognitive impairment. Many benign variants (456 in ClinVar) were also described 
as well as somatic variants implicated in cancer but not associated with germline mutations. 
The MED12 variants examined in the current study were defined as pathogenic by molecular 
modeling, the approach that is not only based on bioinformatic prediction, but also uses 
experimentally gained protein crystal structures. The results suggested a pathogenic effect of 
all four MED12 variants tested: p.(Val954Gly), p.(Glu1091Lys), p.(Arg1295Cys), and 
p.(Pro1371Ser). The other two variants (p.(Arg815Gln) and p.(Arg1148His)) were not 
covered by the models obtained. Despite these results, the maternally inherited MED12 
p.(Pro1371Ser) substitution identified in the sporadic male (Family 6) and also present in 
hemizygous individuals in gnomAD was found to be problematic in the case of the MED12 
variant’s pathogenicity. Because the MED12 variant was found in the proband by X-
chromosome exome re-sequencing, we performed subsequent WES in order to exclude the 
possibility of other variants being engaged in ID pathogenesis. The WES analysis revealed a 
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de novo p.(Arg123Trp) variant in the PUF60 gene. PUF60 variants cause autosomal 
dominant Verheij syndrome which is clinically highly variable. Main clinical symptoms 
include ID, short stature, cerebral atrophy, microcephaly, as well as renal, skeletal, and 
cardiac defects
6
. With the current knowledge, the de novo PUF60 variant identified in this 
study only partially explains the phenotype of the proband from Family 6. The additional 
clinical findings such as macrocephaly, ptosis, Hirschsprung disease, genital hypoplasia, and 
anal anomaly fit in the clinical spectrum of MED12-related disorders and to the best of our 
knowledge have not been reported in probands with PUF60 variants so far. Both, the MED12 
and PUF60 variants were predicted to be pathogenic by molecular modeling and combined 
they better explain the phenotype than each individually. Thus, it is possible that the proband 
from Family 6 presents a complex phenotype caused by these two variants. Such digenic 
inheritance has recently been postulated as an important cause of ID. 
Currently, reports on MED12-related clinical phenotypes in females are rather scarce. 
With the current knowledge, pathogenicity of the firstly reported MED12 p.(Arg1148His) 
substitution in affected females (Family 5)  and assumed as causing Ohdo syndrome in males 
only, by clinical, genetic and functional findings remains to be established
7
. Segregation 
analysis revealed that the variant was inherited from their healthy mother. Although MED12 
is subject to X-inactivation, there was no clear correlation between clinical phenotypes of the 
MED12 carrier females from Family 5 and their XCI pattern in blood cells, similar to the 
results published previously
8
. It seems that blood DNA-based X inactivation does not predict 
clinical outcome in MED12-related carrier females and different affection statuses in females 
might be related to varying X-inactivation in the brain. Thus, it is possible that similar to other 
genes initially implicated in X-linked recessive disorders in males, missense variants in 
MED12 may predict a potential risk for phenotypic expression in carrier females. This 
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assumption needs to be more firmly established in the future, and if confirmed would be 
important for genetic counseling and prognostic evaluation. 
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FIGURE LEGENDS 
Fig. 1 
A Pedigrees of the families with segregation of the MED12 variants (black) and the PUF60 
variant (blue). Mutant alleles are represented by a plus (+) and wild-type alleles by a minus (–
). B The distribution of the MED12 variants in relation to the gene structure consisting of 45 
exons and three functional domains: MED12, LCEWAV, and catenin-binding domain – PQL 
(domain positioning according to Pfam 31.0 database). Known pathogenic MED12 variants 
are indicated above the gene and novel variants below the gene. Asterisks denote MED12 
variants present in affected females. C Images of MED12 probands from the presented 
families. Most of the probands presented with a long narrow face, prominent forehead, 
prominent nasal bridge, small ears, and hypertelorism. Novel facial dysmorphisms that 
expand the phenotypic spectrum of MED12-related disorders include deep set eyes (Families 
1, 5), prognathism (Families 1, 3, 5, 6), anteverted nares (Families 4, 6), and bulbous nasal tip 
(Families 3, 5, 6).   
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Fig. 2 
A Representative models (Yasara Structure) of the MED12 segments 826Ala-1096Leu and 
1278Tyr-1395Glu which harbor variants identified in the families, obtained based on the 
structures of homologous proteins. Glu1091 (E1091) forms a salt bridge with the proximal 
Lys1086, so the missense variants p.(Glu1091Lys) (E1091K), which replaces this interaction 
by an unfavorable Lys-Lys one (cation-cation), decreases protein stability. The amino acid 
substitution Val954Gly (V954G) decreases the protein stability distorting the hydrophobic 
core of the four helix bundle (blue). Arg1295 (R1295) forms a salt bridge with Glu1302 
(E1302) and/or Asp1303 (D1303) and displays pi-pi interactions with Trp1291 (W1291), thus 
stabilizing the relative orientation of two proximal helices. In this view, the p.(Arg1295Cys) 
substitution will destroy all these interactions. It should be noted that three cysteine residues 
are proximal to Arg1295 (Cys1287, Cys1296 and Cys1301), so the Arg1295Cys replacement, 
which introduces another cysteine residue, enables formation of alternative patterns of Cys-
Cys bridges, all of which will interfere with the native one, thus affecting the protein folding. 
Pro1371Ser (P1371S) will increase the local flexibility of the short loop, thereby enabling 
reorientation of the flanking helices, and thus decreasing protein stability.  
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B The analysis (Yasara Structure) of the PUF60 p.(Arg123Trp/Gly) amino acid substitutions. 
Arg123 (R123) is located just before the RRM1/RRM2 motifs of PUF60, in the proximity of 
the linker 
205
ProSerAsnIleGlyGln
210
 (magenta) that separates RRM domains (left). 
Arg123Gly (R123G) replacement only minutely affects the protein structure (middle). The 
change of the polar arginine to the highly hydrophobic tryptophan restricts the conformational 
flexibility of this linker (right), and the relative orientation of both RRM domains changes 
substantially upon RNA binding, thus most likely affecting the affinity of PUF60 to RNA. 
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General  
Intellectual disability + + + + + + + + + 
Developmental delay + + + + + + + + + 
Poor/absent speech   +   +   + 
Speech delay/speech disturbances +  + + +   + + 
Hypernasal speech  +  +     + 
Short stature +   + +    + 
Tall, thin body habitus (marfanoid features)  +     +   
Central nervous system 
Hypotonia + + +   + +  + 
Spasticity with joint contractures +   +      
Seizures and EEG abnormalities + + +    +  + 
Corpus callosum agenesis + + +    +  + 
Mega cisterna magna     +     
Craniofacial 
 
 
Macrocephaly + +  +/-  +  + + 
Microcephaly   +  +     
Dolichocephaly + +        
Brachycephaly     +    + 
Long, narrow face + +   + + +  + 
Triangular face   +       
Coarse face   +      + 
Prominent forehead + + +   + + + + 
Malar flattening  +  +      
Prominent nasal bridge  +   +  + +  
Short philtrum  +      +  
Thick alae nasi   + +      
Small nares        +  
Anteverted nares       +  + 
Bulbous nasal tip      +  + + 
Small ears  +  + +   + + + 
Large ears     +     
Open mouth + +       + 
Narrow lips   + +    +  
High, arched palate + + + +   +   
Cleft Lip/Palate   +  +     
Dental abnormalities  + + + +  +  + 
Maxillary hypoplasia   +       
Micrognathia + + +  +     
Prognathism    +  +  + + 
Facial ticks and grimacing     +     
Hypertelorism +  +    + + + 
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Puffy eyelids +         
Epicanthal Folds   +     + + 
Downslanted palpebral fissures + + +      + 
Upslanted palpebral fissures       +   
Deep set eyes    +    +  
Sparse eyebrows  +     +  + 
Ophtalmologic 
Nystagmus +         
Strabismus + + +   + + +  
Auditory Hearing loss   +      + 
Musculosceletal 
 
 
Skeletal anomaly +  +    +   
Wide neck    +      
Broad thumbs and halluces + +        
Long hands  +  +      
Camptodactyly   +      + 
Single palmar crease       +  + 
Hyperextensible joints  + +  +     
Cardiopulmonary Cardiac anomaly + + +    +  + 
Gastrointestinal 
 
Feeding problems +  + +      
Gastroesophageal reflux +         
Hirschsprung disease   +      + 
Constipation +  + +     + 
Anal anomaly +        + 
Genitourinary 
 
Cryptorchidism  +  +  +  +  + 
Genital hypoplasia   +      + 
Inguinal hernia +   +   +   
Urinary incontinence     +     
Behaviour 
Hyperactive, friendly, affable +    + +   + 
Hyperactive, aggressive, shy  + + + +     
Psychosis  +  +      
 
Table 1. Phenotypic comparison between known MED12 related syndromes and the families presented in the study. Clinical symptoms specific for a given syndrome are 
coloured appropriately (FG, red; L-F, green; Ohdo, blue). Symptoms not described previously that expand the phenotypic spectrum of the MED12 variants are marked in 
bold. “+” in family columns denotes that at least one patient per family was diagnosed with the given feature, “blank“ denotes that none of the family members presented 
the given feature. 
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